Literature DB >> 8271298

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.

S E Benner1, T F Pajak, S M Lippman, C Earley, W K Hong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8271298     DOI： 10.1093/jnci/86.2.140

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Molecular targets for cancer chemoprevention.

Authors:  William N William; John V Heymach; Edward S Kim; Scott M Lippman
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 3.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

Review 4.  Prevention of head and neck cancer.

Authors:  Terry A Day; Angela Chi; Brad Neville; James R Hebert
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

5.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

6.  Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

Authors:  Svenja Nölting; Alessio Giubellino; Yasin Tayem; Karen Young; Michael Lauseker; Petra Bullova; Jan Schovanek; Miriam Anver; Stephanie Fliedner; Márta Korbonits; Burkhard Göke; George Vlotides; Ashley Grossman; Karel Pacak
Journal:  Endocrinology       Date:  2014-04-24       Impact factor: 4.736

7.  Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic.

Authors:  Frank L Meyskens; Gregory A Curt; Dean E Brenner; Gary Gordon; Ronald B Herberman; Olivera Finn; Gary J Kelloff; Samir N Khleif; Caroline C Sigman; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

8.  Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Authors:  Aarti K Bhatia; Ju-Whei Lee; Harlan A Pinto; Charlotte D Jacobs; Paul J Limburg; Philip Rubin; Robert M Arusell; Eamonn P Dunphy; Janardan D Khandekar; Seth A Reiner; Luis Baez-Diaz; Paul Celano; Shuli Li; Yi Li; Barbara A Burtness; George L Adams; Kishan J Pandya
Journal:  Cancer       Date:  2017-08-07       Impact factor: 6.860

Review 9.  Clinical studies in head and neck cancer chemoprevention.

Authors:  P M Gonzalez; S E Benner
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Partial replacement of dietary casein with soy protein isolate can reduce the severity of retinoid-induced hypertriglyceridemia.

Authors:  J D Radcliffe; D M Czajka-Narins
Journal:  Plant Foods Hum Nutr       Date:  1998       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.